Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/comparison-of-the-lymph2cx-assay-and-hans-algorithm-in-determining-the-fWXNlSFlnQ
References (40)
-
A. Batlle-López, S. Villambrosía, M. Francisco, Sefora Malatxeberria, A. Sáez, C. Montalbán, L. Sánchez, Juan García, E. González-Barca, A. López‐Hernandez, M. Ruiz-Marcellan, M. Mollejo, C. Grande, K. Richards, E. Hsi, A. Tzankov, C. Visco, Xu Zijun, Xin Cao, K. Young, M. Piris, E. Conde, S. Montes-Moreno (2016)
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible markerOncotarget, 7
-
A. Rosenwald, George Wright, W. Chan, J. Connors, E. Campo, R. Fisher, R. Gascoyne, H. Muller-Hermelink, E. Smeland, J. Giltnane, E. Hurt, Hong Zhao, Lauren Averett, Liming Yang, W. Wilson, E. Jaffe, R. Simon, R. Klausner, J. Powell, P. Duffey, D. Longo, T. Greiner, D. Weisenburger, W. Sanger, B. Dave, J. Lynch, J. Vose, J. Armitage, E. Montserrat, A. López-Guillermo, T. Grogan, T. Miller, M. LeBlanc, G. Ott, S. Kvaløy, J. Delabie, H. Holte, P. Krajči, T. Stokke, L. Staudt (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.The New England journal of medicine, 346 25
-
Alejandra Carvajal-Cuenca, S. Pileri, E. Campo (2013)
The World Health Organization Classification of Lymphoid Neoplasms -
David Scott, G. Wright, P. Williams, C. Lih, W. Walsh, Elaine Jaffe, A. Rosenwald, E. Campo, Wing Chan, J. Connors, E. Smeland, A. Mottok, R. Braziel, G. Ott, J. Delabie, Raymond Tubbs, J. Cook, D. Weisenburger, T. Greiner, B. Glinsmann-Gibson, K. Fu, L. Staudt, R. Gascoyne, L. Rimsza (2014)
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.Blood, 123 8
-
R. Davis, V. Ngo, G. Lenz, P. Tolar, R. Young, P. Romesser, H. Kohlhammer, L. Lamy, Hong Zhao, Yandan Yang, Weihong Xu, A. Shaffer, George Wright, Wenming Xiao, J. Powell, Jian-Kang Jiang, Craig Thomas, A. Rosenwald, G. Ott, H. Müller-hermelink, R. Gascoyne, J. Connors, N. Johnson, L. Rimsza, E. Campo, E. Jaffe, W. Wilson, J. Delabie, E. Smeland, R. Fisher, R. Braziel, R. Tubbs, J. Cook, D. Weisenburger, W. Chan, S. Pierce, L. Staudt (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaNature, 463
-
C. Hans, D. Weisenburger, T. Greiner, R. Gascoyne, J. Delabie, G. Ott, H. Müller-hermelink, E. Campo, R. Braziel, E. Jaffe, Zenggang Pan, Pedro Farinha, Lynette Smith, B. Falini, A. Banham, A. Rosenwald, L. Staudt, J. Connors, J. Armitage, W. Chan (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.Blood, 103 1
-
W. Wilson, R. Young, R. Schmitz, Yandan Yang, S. Pittaluga, George Wright, C. Lih, P. Williams, A. Shaffer, J. Gerecitano, J. Gerecitano, S. Vos, A. Goy, V. Kenkre, P. Barr, K. Blum, A. Shustov, R. Advani, N. Fowler, J. Vose, R. Elstrom, T. Habermann, J. Barrientos, J. Mcgreivy, M. Fardis, B. Chang, F. Clow, B. Munneke, D. Moussa, D. Beaupre, L. Staudt (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaNature Medicine, 21
-
G. Nowakowski, A. Chiappella, T. Witzig, M. Spina, R. Gascoyne, Lei Zhang, J. Flament, Jacqueline Repici, U. Vitolo (2016)
ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphomaFuture Oncology, 12
-
D. Scott (2015)
Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic?American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
-
P. Reis, L. Waldron, R. Goswami, Wei Xu, Y. Xuan, B. Perez–Ordoñez, P. Gullane, J. Irish, I. Jurisica, S. Kamel‐Reid (2011)
mRNA transcript quantification in archival samples using multiplexed, color-coded probesBMC Biotechnology, 11
-
S. Barton, E. Hawkes, A. Wotherspoon, D. Cunningham (2012)
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?The oncologist, 17 12
-
D. Jong, A. Rosenwald, M. Chhanabhai, P. Gaulard, W. Klapper, Abigail Lee, B. Sander, C. Thorns, E. Campo, T. Molina, A. Norton, A. Hagenbeek, S. Horning, A. Lister, J. Raemaekers, R. Gascoyne, G. Salles, E. Weller (2007)
Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)Journal of Clinical Pathology, 62
-
D. Scott, A. Mottok, D. Ennishi, George Wright, P. Farinha, S. Ben-Neriah, R. Kridel, Garrett Barry, C. Hother, P. Abrisqueta, M. Boyle, B. Meissner, A. Telenius, K. Savage, L. Sehn, G. Slack, C. Steidl, L. Staudt, J. Connors, L. Rimsza, R. Gascoyne (2015)
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 26
-
(2017)
World Health Organization classification of tumours of haematopoietic and lymphoid tissues -
N. Yoon, Soomin Ahn, H. Yoo, S. Kim, W. Kim, Y. Ko (2017)
Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithmOncotarget, 8
-
Mareike Frick, B. Dörken, G. Lenz (2011)
The molecular biology of diffuse large B-cell lymphomaTherapeutic Advances in Hematology, 2
-
Veldman-Jones (2015)
Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical SamplesCancer Res, 75
-
(2014)
Determining cell-oforigin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue -
D. Scott, F. Chan, F. Hong, S. Rogic, K. Tan, B. Meissner, S. Ben-Neriah, M. Boyle, R. Kridel, A. Telenius, B. Woolcock, Pedro Farinha, R. Fisher, L. Rimsza, N. Bartlett, B. Cheson, L. Shepherd, R. Advani, J. Connors, B. Kahl, L. Gordon, S. Horning, C. Steidl, R. Gascoyne (2013)
Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 6
-
Ash Alizadeh, M. Eisen, R. Davis, Chishieva Ma, I. Lossos, A. Rosenwald, Jennifer Boldrick, H. Sabet, T. Tran, Xin Yu, J. Powell, Liming Yang, G. Marti, T. Moore, J. Hudson, Li-Sheng Lu, D. Lewis, R. Tibshirani, G. Sherlock, W. Chan, T. Greiner, D. Weisenburger, J. Armitage, R. Warnke, R. Levy, W. Wilson, M. Grever, J. Byrd, D. Botstein, P. Brown, L. Staudt (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 403
-
G. Lenz, George Wright, S. Dave, Wenming Xiao, J. Powell, Huaqing Zhao, Wei Xu, Bruce Tan, N. Goldschmidt, J. Iqbal, J. Vose, M. Bast, K. Fu, D. Weisenburger, T. Greiner, J. Armitage, A. Kyle, L. May, R. Gascoyne, J. Connors, G. Trøen, H. Holte, S. Kvaløy, D. Dierickx, G. Verhoef, J. Delabie, E. Smeland, P. Jares, A. Martínez, A. López-Guillermo, E. Montserrat, E. Campo, R. Braziel, T. Miller, L. Rimsza, J. Cook, B. Pohlman, J. Sweetenham, R. Tubbs, R. Fisher, E. Hartmann, A. Rosenwald, G. Ott, G. Ott, H. Müller-Hermelink, D. Wrench, T. Lister, E. Jaffe, W. Wilson, W. Chan, L. Staudt (2008)
Stromal gene signatures in large-B-cell lymphomas.The New England journal of medicine, 359 22
-
M. Ott, H. Horn, M. Kaufmann, G. Ott (2012)
The Hans classificator does not predict outcome in diffuse large B cell lymphoma in a large multicenter retrospective analysis of R-CHOP treated patients.Leukemia research, 36 5
-
G. Gutiérrez-García, T. Cardesa-Salzmann, F. Climent, E. González-Barca, S. Mercadal, J. Mate, J. Sancho, L. Arenillas, S. Serrano, L. Escoda, S. Martínez, Alexandra Valera, Antonio Martínez, P. Jares, M. Pinyol, A. García-Herrera, A. Martínez‐Trillos, E. Giné, N. Villamor, E. Campo, L. Colomo, A. López-Guillermo (2011)
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.Blood, 117 18
-
Swerdlow (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 127
-
A. Udager, D. Rolland, Jonathan McHugh, B. Betz, C. Murga-Zamalloa, Thomas Carey, L. Marentette, Mario Hermsen, Kathleen Duross, Megan Lim, K. Elenitoba-Johnson, Noah Brown (2015)
High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.Cancer research, 75 13
-
C. Visco, Y. Li, Z. Xu-Monette, R. Miranda, T. Green, A. Tzankov, W. Wen, W. Liu, B. Kahl, E. d'Amore, S. Montes-Moreno, K. Dybkær, A. Chiu, W. Tam, A. Orazi, Y. Zu, G. Bhagat, J. Winter, H-Y Wang, S. O'Neill, C. Dunphy, E. Hsi, X. Zhao, R. Go, W. Choi, F. Zhou, M. Czader, J. Tong, X. Zhao, J. Krieken, Q. Huang, W. Ai, J. Etzell, M. Ponzoni, A. Ferreri, M. Piris, M. Møller, C. Bueso-Ramos, L. Medeiros, L. Wu, K. Young (2012)
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyLeukemia, 26
-
(2016)
Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma -
Paul Meyer, K. Fu, T. Greiner, Lynette Smith, J. Delabie, R. Gascoyne, G. Ott, A. Rosenwald, R. Braziel, E. Campo, J. Vose, G. Lenz, L. Staudt, W. Chan, D. Weisenburger (2011)
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 2
-
J. Jais, T. Molina, P. Ruminy, D. Gentien, C. Reyes, D. Scott, L. Rimsza, George Wright, R. Gascoyne, L. Staudt, C. Haioun, H. Tilly, P. Gaulard, G. Salles, F. Jardin, K. Leroy (2017)
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assayHaematologica, 102
-
S. Barrans, S. Crouch, M. Care, L. Worrillow, Alex Smith, R. Patmore, D. Westhead, R. Tooze, E. Roman, A. Jack (2012)
Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B‐cell lymphoma and predict clinical outcomeBritish Journal of Haematology, 159
-
Y. Natkunam, P. Farinha, E. Hsi, C. Hans, R. Tibshirani, L. Sehn, J. Connors, D. Gratzinger, M. Rosado, Shuchun Zhao, B. Pohlman, Nicholas Wongchaowart, M. Bast, A. Avigdor, G. Schiby, A. Nagler, G. Byrne, R. Levy, R. Gascoyne, I. Lossos (2008)
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 3
-
de Jong (2007)
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications—a study from the Lunenburg Lymphoma Biomarker ConsortiumJ Clin Oncol, 25
-
B. Coiffier (2001)
Diffuse large cell lymphoma.Current opinion in oncology, 13 5
-
G. Lenz, George Wright, N. Emre, H. Kohlhammer, S. Dave, R. Davis, S. Carty, L. Lam, A. Shaffer, Wenming Xiao, J. Powell, A. Rosenwald, G. Ott, G. Ott, H. Müller-hermelink, R. Gascoyne, J. Connors, E. Campo, E. Jaffe, J. Delabie, E. Smeland, L. Rimsza, R. Fisher, D. Weisenburger, W. Chan, L. Staudt (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysProceedings of the National Academy of Sciences, 105
-
K. Phang, A. Akhter, Nur Tizen, F. Rahman, Raja Azma, G. Elyamany, M. Shabani‐Rad, N. Masir, A. Mansoor (2017)
Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in MalaysiaJournal of Clinical Pathology, 71
-
George Wright, Bruce Tan, A. Rosenwald, Elaine Hurt, A. Wiestner, L. Staudt (2003)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphomaProceedings of the National Academy of Sciences of the United States of America, 100
-
K. Fu, D. Weisenburger, W. Choi, Kyle Perry, Lynette Smith, Xinlan Shi, C. Hans, T. Greiner, P. Bierman, R. Bociek, J. Armitage, W. Chan, J. Vose (2008)
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 28
-
G. Geiss, Roger Bumgarner, Brian Birditt, Timothy Dahl, N. Dowidar, D. Dunaway, H. Fell, S. Ferree, Renee George, Tammy Grogan, Jeffrey James, Malini Maysuria, Jeffrey Mitton, P. Oliveri, Jennifer Osborn, Tao Peng, A. Ratcliffe, Philippa Webster, E. Davidson, L. Hood, Krassen Dimitrov (2008)
Direct multiplexed measurement of gene expression with color-coded probe pairsNature Biotechnology, 26
-
W. Choi, D. Weisenburger, T. Greiner, M. Piris, A. Banham, J. Delabie, R. Braziel, H. Geng, J. Iqbal, G. Lenz, J. Vose, C. Hans, K. Fu, Lynette Smith, Min Li, Zhongfeng Liu, R. Gascoyne, A. Rosenwald, G. Ott, L. Rimsza, E. Campo, E. Jaffe, D. Jaye, L. Staudt, W. Chan (2009)
A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High AccuracyClinical Cancer Research, 15
-
A. Ng (2007)
Diffuse large B-cell lymphoma.Seminars in radiation oncology, 17 3
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
- ISSN
- 1541-2016
- DOI
- 10.1097/PAI.0000000000000843
- Publisher site
- See Article on Publisher Site
Abstract
Supplemental Digital Content is available in the text.
Journal
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Nov 13, 2020